154 related articles for article (PubMed ID: 1698671)
1. Differential expression of fetomodulin and tissue plasminogen activator to characterize parietal endoderm differentiation of F9 embryonal carcinoma cells.
Imada S; Yamaguchi H; Imada M
Dev Biol; 1990 Oct; 141(2):426-30. PubMed ID: 1698671
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid modulation of transmembrane signaling. Analysis in F9 teratocarcinoma cells.
Galvin-Parton PA; Watkins DC; Malbon CC
J Biol Chem; 1990 Oct; 265(29):17771-9. PubMed ID: 2170395
[TBL] [Abstract][Full Text] [Related]
3. Cellular HSP90 (HSP86) mRNA level and in vitro differentiation of mouse embryonal carcinoma (F9) cells.
Kohda T; Kondo K; Oishi M
FEBS Lett; 1991 Sep; 290(1-2):107-10. PubMed ID: 1655528
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid-induced transition from protein kinase C beta to protein kinase C alpha in differentiated F9 cells: correlation with altered regulation of proto-oncogene expression by phorbol esters.
Khuri FR; Cho Y; Talmage DA
Cell Growth Differ; 1996 May; 7(5):595-602. PubMed ID: 8732669
[TBL] [Abstract][Full Text] [Related]
5. Localization of endoderm-specific mRNAs in differentiating F9 embryoid bodies.
Becker S; Casanova J; Grabel L
Mech Dev; 1992 Mar; 37(1-2):3-12. PubMed ID: 1376612
[TBL] [Abstract][Full Text] [Related]
6. Expression of a parathyroid hormone-like protein and its receptor during differentiation of embryonal carcinoma cells.
Chan SD; Strewler GJ; King KL; Nissenson RA
Mol Endocrinol; 1990 Apr; 4(4):638-46. PubMed ID: 2177844
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator expression in F9 teratocarcinoma embryoid bodies and their endoderm derivatives.
Sabbag KR; Casanova JE; Grabel LB
Development; 1989 May; 106(1):195-201. PubMed ID: 2516796
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid, dibutyryl-cAMP, and differentiation affect the expression of retinoic acid receptors in F9 cells.
Martin CA; Ziegler LM; Napoli JL
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4804-8. PubMed ID: 2162058
[TBL] [Abstract][Full Text] [Related]
9. Neuron-like derivatives of cultured F9 embryonal carcinoma cells express characteristics of parietal endoderm cells.
Tienari J; Virtanen I; Soinila S; Lehtonen E
Dev Biol; 1987 Oct; 123(2):566-73. PubMed ID: 2820818
[TBL] [Abstract][Full Text] [Related]
10. Reversible interconversion between primitive endoderm- and parietal endoderm-like F9 cells demonstrated by mRNAs expression.
Miki K; Sugimoto E; Kitagawa Y
J Biochem; 1987 Aug; 102(2):385-92. PubMed ID: 2822687
[TBL] [Abstract][Full Text] [Related]
11. Thrombomodulin gene regulation by cAMP and retinoic acid in F9 embryonal carcinoma cells.
Weiler-Guettler H; Yu K; Soff G; Gudas LJ; Rosenberg RD
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2155-9. PubMed ID: 1312715
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the cytoskeleton-extracellular matrix linkage promotes the accumulation of plasminogen activators in F9 derived parietal endoderm.
Snyder RW; Lenburg ME; Seebaum AT; Grabel LB
Differentiation; 1992 Aug; 50(3):153-62. PubMed ID: 1330791
[TBL] [Abstract][Full Text] [Related]
13. Embryonal carcinoma cells differentiate into parietal endoderm via an intermediate stage corresponding to primitive endoderm.
Damjanov I; Zhu ZM; Andrews PW; Fenderson BA
In Vivo; 1994; 8(6):967-73. PubMed ID: 7772748
[TBL] [Abstract][Full Text] [Related]
14. Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases.
Kondo K; Tsuneizumi K; Watanabe T; Oishi M
Cancer Res; 1991 Oct; 51(19):5398-404. PubMed ID: 1680548
[TBL] [Abstract][Full Text] [Related]
15. Identification of a major poly-N-acetyllactosamine-containing cell-surface glycoprotein of mouse teratocarcinoma cells. Appearance on cells induced to primitive endoderm but not parietal endoderm differentiation.
Spillmann D; Finne J
Eur J Biochem; 1994 Mar; 220(2):385-94. PubMed ID: 8125095
[TBL] [Abstract][Full Text] [Related]
16. Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP.
Strickland S; Smith KK; Marotti KR
Cell; 1980 Sep; 21(2):347-55. PubMed ID: 6250719
[TBL] [Abstract][Full Text] [Related]
17. Lectin binding of F9 embryonal carcinoma cells: evidence for population heterogeneity and developmentally regulated high-Mr cell surface proteins.
Tienari J; Virtanen I; Lehtonen E
J Cell Sci; 1989 Apr; 92 ( Pt 4)():561-8. PubMed ID: 2557358
[TBL] [Abstract][Full Text] [Related]
18. Modulation of alpha 6/beta 1 integrin expression during differentiation of F9 murine embryonal carcinoma cells to parietal endoderm.
Morini M; Piccini D; Barbieri O; Astigiano S
Exp Cell Res; 1997 May; 232(2):304-12. PubMed ID: 9168806
[TBL] [Abstract][Full Text] [Related]
19. Anti-sense inhibition of tissue plasminogen activator production in differentiated F9 teratocarcinoma cells.
Pecorino LT; Rickles RJ; Strickland S
Dev Biol; 1988 Oct; 129(2):408-16. PubMed ID: 2458288
[TBL] [Abstract][Full Text] [Related]
20. Butyrate inhibits the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells.
Levine RA; Campisi J; Wang SY; Gudas LJ
Dev Biol; 1984 Oct; 105(2):443-50. PubMed ID: 6090244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
